Medication related adverse effects (Asthma/COPD)

PULM_MEDICATIO_COMORB

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
PULM_MEDICATIO_COMORB

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 57975 29951 28024
Unadjusted prevalence (%) 18.79 17.26 20.76
Mean age at first event (years) 68.00 67.55 68.49

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.71 [2.48, 2.96] <1e-100 11551
15 years 0.01 1.52 [1.38, 1.66] 3.7e-19 5323
5 years 0.00 2.82 [2.61, 3.05] <1e-100 3966
1 year 0.00 4.83 [4.31, 5.41] <1e-100 1472

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: PULM_MEDICATIO_COMORB – Medication related adverse effects (Asthma/COPD)
GWS hits:

Survival analyses between endpoints

Plot

before Medication related adverse effects (Asthma/COPD)
after Medication related adverse effects (Asthma/COPD)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Medication related adverse effects (Asthma/COPD)